Patent application number | Description | Published |
20080242631 | Impaired wound healing compositions and treatments - Connexin modulation for the treatment of wounds that do not heal at expected rates, including delayed healing wounds, incompletely healing wounds, and chronic wounds, and associated methods, compositions and articles. | 10-02-2008 |
20090220450 | Methods and compositions for wound healing - Methods and compositions comprising combinations of one or more anti-connexin agents and one or more other agents useful for the promotion and/or improvement of wound healing and/or tissue repair. | 09-03-2009 |
20110223204 | TREATMENT OF PAIN WITH GAP JUNCTION MODULATION COMPOUNDS - The present invention relates to delivery, including transdermal delivery, of a therapeutically effective amount of a compound useful for modulating gap junction formation and function, including an oligonucleotide for reducing gap junction formation and function, and methods and compositions for treating a subject suffering from pain associated with a disease, disorder or condition and associated with pain, including but not limited to muscle pain, ligament pain, tendon pain, joint pain and post-operative pain. | 09-15-2011 |
20120196799 | Amylin Family Peptides and Methods for Making and Using Them - Methods for treating obesity are disclosed which comprise administration of a therapeutically effective amount of an amylin or an amylin agonist alone or in conjunction with another obesity relief agent. Additionally, methods for reducing insulin-induced weight gain are disclosed which comprise administration of a therapeutically effective amount of an amylin or an amylin agonist. | 08-02-2012 |
20120289579 | IMPAIRED WOUND HEALING COMPOSITIONS AND TREATMENTS - Connexin modulation for the treatment of wounds that do not heal at expected rates, including delayed healing wounds, incompletely healing wounds, and chronic wounds, and associated methods, compositions and articles. | 11-15-2012 |
20130143952 | IMPAIRED WOUND HEALING COMPOSITIONS AND METHODS - Connexin modulation for the treatment of wounds that do not heal at expected rates, including delayed healing wounds, incompletely healing wounds, and chronic wounds, and associated methods, compositions and articles. | 06-06-2013 |
20130243734 | METHODS AND COMPOSITIONS FOR WOUND HEALING - Methods and compositions comprising combinations of one or more anti-connexin agents and one or more other agents useful for the promotion and/or improvement of wound healing and/or tissue repair. | 09-19-2013 |
20140274872 | COMPOSITIONS AND TREATMENTS BASED ON CADHERIN MODULATION - Anti-cadherin and anti-ZO-1 agents and compositions, and kits containing them for use in the promotion and/or improvement of wound healing and/or tissue repair, and for anti-scarring, anti-inflammatory, anti-fibrosis and anti-adhesion indications. | 09-18-2014 |
Patent application number | Description | Published |
20100279921 | IMPAIRED WOUND HEALING COMPOSITIONS AND TREATMENTS - Methods and compositions comprising combinations and uses of a first anti-connexin agent and a second anti-connexin agent, for example, one or more anti-connexin polynucleotides and one or more anti-connexin peptides or peptidomimetics, are provided for therapeutic use including uses for the promotion and/or improvement of wounds and wound healing and/or tissue repair. | 11-04-2010 |
20110038920 | WOUND HEALING COMPOSITIONS AND TREATMENTS - Methods and compositions comprising an anti-ostepontin agent and/or a PDGF receptor blocker or antagonist, alone or in combination with one or more anti-connexin agents, for example, one or more anti-connexin polynucleotides and/or one or more anti-connexin peptides or peptidomimetics, are provided for the promotion and/or improvement of wound healing and/or tissue repair, and for anti-scarring, anti-inflammatory, anti-fibrosis and anti-adhesion indications. | 02-17-2011 |
20110092449 | TREATMENT OF FIBROTIC CONDITIONS - Compositions, articles, devices and methods for the treatment of fibrosis and fibrotic diseases, disorders, and conditions in humans and non-human animals. | 04-21-2011 |
20110136890 | TREATMENT OF FIBROTIC CONDITIONS - Treatment of fibrosis and fibrotic diseases, disorders, and conditions, and associated methods, compositions, formulations and articles. | 06-09-2011 |
20110144182 | TREATMENT OF SURGICAL ADHESIONS - Connexin modulation for the treatment of surgical adhesions, and associated methods, compositions, and articles. | 06-16-2011 |
20110166653 | MEDICAL DEVICES - Medical devices comprising an anti-connexin agent suitable for introduction into a subject. | 07-07-2011 |
20110217313 | TREATMENT OF ORTHOPEDIC CONDITIONS - Methods, compounds, compositions, kits and articles of manufacture comprising anti-connexin agents for treatment of orthopedic disorder, disease, or condition, and promoting post-surgical wound-healing. | 09-08-2011 |
20110243964 | TREATMENT OF ORTHOPEDIC CONDITIONS - Methods, compounds, compositions, kits and articles of manufacture comprising anti-connexin agents for treatment of orthopedic disorders, diseases, or conditions, and improving recoveries and outcomes of orthopedic procedures or surgeries. | 10-06-2011 |
20110245184 | TREATMENT OF SURGICAL ADHESIONS - Compositions, articles, devices and methods for the treatment and/or prevention of adhesions in humans and non-human animals. | 10-06-2011 |
20110300130 | IMPAIRED WOUND HEALING COMPOSITIONS AND TREATMENTS - Methods, compounds, compositions, kits and articles of manufacture comprising one or more gap junction modulating agents for treatment of wounds that do not heal at expected rates, including chronic wounds, delayed healing wounds, incompletely healing wounds, and dehiscent wounds in a subject in need thereof. | 12-08-2011 |
20130184220 | TREATMENT OF ABNORMAL OR EXCESSIVE SCARS - Methods and compositions comprising combinations and uses of a first anti-connexin agent and a second anti-connexin agent, for example, one or more anti-connexin polynucleotides and one or more anti-connexin peptides or peptidomimetics, are provided for the treatmen or prevention of abnormal or excessive scarring. | 07-18-2013 |